Register-based information on thyroid diseases in Europe : lessons and results from the EUthyroid collaboration - Møllehave, Line Tang (Bispebjerg and Frederiksberg Hospitals (Copenhagen, Dinamarca)) ; Eliasen, Marie Holm (Bispebjerg and Frederiksberg Hospitals (Copenhagen, Dinamarca)) ; Linneberg, Allan (University of Copenhagen) ; Moreno-Reyes, Rodrigo (Université Libre de Bruxelles) ; Ivanova, Ludmila B. (Faculty of Medicine) ; Kusić, Zvonko (School of Medicine) ; Erlund, Iris (Department of Government Services) ; Ittermann, Till (Institute for Community Medicine) ; Nagy, Endre V (Division of Endocrinology) ; Gunnarsdottir, Ingibjorg (University of Iceland) ; Arbelle, Jonathan Eli (Goldman School of Medicine) ; Troen, Aaron Milton (The Hebrew University of Jerusalem) ; Pīrāgs, Valdis (University of Latvia) ; Dahl, Lisbeth (Institute of Marine Research (Noruega)) ; Hubalewska-Dydejczyk, Alicja (Jagiellonian University, Medical College) ; Trofimiuk-Müldner, Malgorzata (Jagiellonian University, Medical College) ; de Castro, João Jacome (Armed Forces Hospital (Portugal)) ; Marcelino, Mafalda (Armed Forces Hospital (Portugal)) ; Gaberšček, Simona (University Medical Centre Ljubljana) ; Zaltel, Katja (University Medical Centre Ljubljana) ; Puig Domingo, Manuel (Institut Germans Trias i Pujol) ; Vila, Lluís (Hospital de Sant Joan Despí Moisès Broggi) ; Manousou, Sofia (Frölunda Specialist Hospital) ; Nyström, Helena Filipsson (Wallenberg Centre of Molecular and Translational Medicine) ; Zimmermann, Michael Bruce (ETH Zurich) ; Mullan, Karen R. (Belfast Health and Social Care Trust) ; Woodside, Jayne Valerie (Queen's University Belfast) ; Völzke, Henry (University Medicine Greifswald) ; Thuesen, Betina Heinsbæk (Bispebjerg and Frederiksberg Hospitals (Copenhagen, Dinamarca)) ; Universitat Autònoma de Barcelona
 
Comentaris (0) | Ressenyes (0)
Sigueu el primer a escriure una ressenya d'aquest document.

Afegiu la vostra ressenya

Valoreu aquest article:
Doneu un títol a la vostra ressenya:
Escriviu la vostra ressenya:
Vigileu: encara no heu definit el vostre àlies.
N/D s'usarà temporalment com a autor d'aquest comentari.